Latest return on equity

Immix Biopharma Return on equity

Direct answer

Immix Biopharma's return on equity is -34.18%.

The verified market snapshot reports -34.18%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.

Get free Immix Biopharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Return on equity
-34.18%